Global Artificial Intelligence-driven Drug Development Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Artificial Intelligence-driven Drug Development market size is projected to grow from US$ 1336.6 million in 2022 to US$ 9237.4 million in 2029; it is expected to grow at a CAGR of 31.8% from 2023 to 2029.
United States market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artificial Intelligence-driven Drug Development players cover IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
LPI (LP Information)' newest research report, the “Artificial Intelligence-driven Drug Development Industry Forecast” looks at past sales and reviews total world Artificial Intelligence-driven Drug Development sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence-driven Drug Development sales for 2023 through 2029. With Artificial Intelligence-driven Drug Development sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence-driven Drug Development industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence-driven Drug Development landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Intelligence-driven Drug Development portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence-driven Drug Development market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence-driven Drug Development and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence-driven Drug Development.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence-driven Drug Development market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Artificial Intelligence-driven Drug Development market size is projected to grow from US$ 1336.6 million in 2022 to US$ 9237.4 million in 2029; it is expected to grow at a CAGR of 31.8% from 2023 to 2029.
United States market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artificial Intelligence-driven Drug Development players cover IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
LPI (LP Information)' newest research report, the “Artificial Intelligence-driven Drug Development Industry Forecast” looks at past sales and reviews total world Artificial Intelligence-driven Drug Development sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence-driven Drug Development sales for 2023 through 2029. With Artificial Intelligence-driven Drug Development sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence-driven Drug Development industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence-driven Drug Development landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Intelligence-driven Drug Development portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence-driven Drug Development market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence-driven Drug Development and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence-driven Drug Development.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence-driven Drug Development market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Hardware
- Software
- Service
- Early Drug Discovery
- Preclinical Phase
- Clinical Phase
- Regulatory Approval
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IBM
- Exscientia
- Google(Alphabet)
- Microsoft
- Atomwise
- Schrodinger
- Aitia
- Insilico Medicine
- NVIDIA
- XtalPi
- BPGbio
- Owkin
- CytoReason
- Deep Genomics
- Cloud Pharmaceuticals
- BenevolentAI
- Cyclica
- Verge Genomics
- Valo Health
- Envisagenics
- Euretos
- BioAge Labs
- Iktos
- BioSymetrics
- Evaxion Biotech
- Aria Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence-driven Drug Development Market Size 2018-2029
2.1.2 Artificial Intelligence-driven Drug Development Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Artificial Intelligence-driven Drug Development Segment by Type
2.2.1 Hardware
2.2.2 Software
2.2.3 Service
2.3 Artificial Intelligence-driven Drug Development Market Size by Type
2.3.1 Artificial Intelligence-driven Drug Development Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
2.4 Artificial Intelligence-driven Drug Development Segment by Application
2.4.1 Early Drug Discovery
2.4.2 Preclinical Phase
2.4.3 Clinical Phase
2.4.4 Regulatory Approval
2.5 Artificial Intelligence-driven Drug Development Market Size by Application
2.5.1 Artificial Intelligence-driven Drug Development Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
3 ARTIFICIAL INTELLIGENCE-DRIVEN DRUG DEVELOPMENT MARKET SIZE BY PLAYER
3.1 Artificial Intelligence-driven Drug Development Market Size Market Share by Players
3.1.1 Global Artificial Intelligence-driven Drug Development Revenue by Players (2018-2023)
3.1.2 Global Artificial Intelligence-driven Drug Development Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence-driven Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE-DRIVEN DRUG DEVELOPMENT BY REGIONS
4.1 Artificial Intelligence-driven Drug Development Market Size by Regions (2018-2023)
4.2 Americas Artificial Intelligence-driven Drug Development Market Size Growth (2018-2023)
4.3 APAC Artificial Intelligence-driven Drug Development Market Size Growth (2018-2023)
4.4 Europe Artificial Intelligence-driven Drug Development Market Size Growth (2018-2023)
4.5 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Artificial Intelligence-driven Drug Development Market Size by Country (2018-2023)
5.2 Americas Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023)
5.3 Americas Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence-driven Drug Development Market Size by Region (2018-2023)
6.2 APAC Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023)
6.3 APAC Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence-driven Drug Development by Country (2018-2023)
7.2 Europe Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023)
7.3 Europe Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence-driven Drug Development by Region (2018-2023)
8.2 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023)
8.3 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE-DRIVEN DRUG DEVELOPMENT MARKET FORECAST
10.1 Global Artificial Intelligence-driven Drug Development Forecast by Regions (2024-2029)
10.1.1 Global Artificial Intelligence-driven Drug Development Forecast by Regions (2024-2029)
10.1.2 Americas Artificial Intelligence-driven Drug Development Forecast
10.1.3 APAC Artificial Intelligence-driven Drug Development Forecast
10.1.4 Europe Artificial Intelligence-driven Drug Development Forecast
10.1.5 Middle East & Africa Artificial Intelligence-driven Drug Development Forecast
10.2 Americas Artificial Intelligence-driven Drug Development Forecast by Country (2024-2029)
10.2.1 United States Artificial Intelligence-driven Drug Development Market Forecast
10.2.2 Canada Artificial Intelligence-driven Drug Development Market Forecast
10.2.3 Mexico Artificial Intelligence-driven Drug Development Market Forecast
10.2.4 Brazil Artificial Intelligence-driven Drug Development Market Forecast
10.3 APAC Artificial Intelligence-driven Drug Development Forecast by Region (2024-2029)
10.3.1 China Artificial Intelligence-driven Drug Development Market Forecast
10.3.2 Japan Artificial Intelligence-driven Drug Development Market Forecast
10.3.3 Korea Artificial Intelligence-driven Drug Development Market Forecast
10.3.4 Southeast Asia Artificial Intelligence-driven Drug Development Market Forecast
10.3.5 India Artificial Intelligence-driven Drug Development Market Forecast
10.3.6 Australia Artificial Intelligence-driven Drug Development Market Forecast
10.4 Europe Artificial Intelligence-driven Drug Development Forecast by Country (2024-2029)
10.4.1 Germany Artificial Intelligence-driven Drug Development Market Forecast
10.4.2 France Artificial Intelligence-driven Drug Development Market Forecast
10.4.3 UK Artificial Intelligence-driven Drug Development Market Forecast
10.4.4 Italy Artificial Intelligence-driven Drug Development Market Forecast
10.4.5 Russia Artificial Intelligence-driven Drug Development Market Forecast
10.5 Middle East & Africa Artificial Intelligence-driven Drug Development Forecast by Region (2024-2029)
10.5.1 Egypt Artificial Intelligence-driven Drug Development Market Forecast
10.5.2 South Africa Artificial Intelligence-driven Drug Development Market Forecast
10.5.3 Israel Artificial Intelligence-driven Drug Development Market Forecast
10.5.4 Turkey Artificial Intelligence-driven Drug Development Market Forecast
10.5.5 GCC Countries Artificial Intelligence-driven Drug Development Market Forecast
10.6 Global Artificial Intelligence-driven Drug Development Forecast by Type (2024-2029)
10.7 Global Artificial Intelligence-driven Drug Development Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 IBM
11.1.1 IBM Company Information
11.1.2 IBM Artificial Intelligence-driven Drug Development Product Offered
11.1.3 IBM Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 IBM Main Business Overview
11.1.5 IBM Latest Developments
11.2 Exscientia
11.2.1 Exscientia Company Information
11.2.2 Exscientia Artificial Intelligence-driven Drug Development Product Offered
11.2.3 Exscientia Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Exscientia Main Business Overview
11.2.5 Exscientia Latest Developments
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Information
11.3.2 Google(Alphabet) Artificial Intelligence-driven Drug Development Product Offered
11.3.3 Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Google(Alphabet) Main Business Overview
11.3.5 Google(Alphabet) Latest Developments
11.4 Microsoft
11.4.1 Microsoft Company Information
11.4.2 Microsoft Artificial Intelligence-driven Drug Development Product Offered
11.4.3 Microsoft Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Microsoft Main Business Overview
11.4.5 Microsoft Latest Developments
11.5 Atomwise
11.5.1 Atomwise Company Information
11.5.2 Atomwise Artificial Intelligence-driven Drug Development Product Offered
11.5.3 Atomwise Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Atomwise Main Business Overview
11.5.5 Atomwise Latest Developments
11.6 Schrodinger
11.6.1 Schrodinger Company Information
11.6.2 Schrodinger Artificial Intelligence-driven Drug Development Product Offered
11.6.3 Schrodinger Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Schrodinger Main Business Overview
11.6.5 Schrodinger Latest Developments
11.7 Aitia
11.7.1 Aitia Company Information
11.7.2 Aitia Artificial Intelligence-driven Drug Development Product Offered
11.7.3 Aitia Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aitia Main Business Overview
11.7.5 Aitia Latest Developments
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Information
11.8.2 Insilico Medicine Artificial Intelligence-driven Drug Development Product Offered
11.8.3 Insilico Medicine Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Insilico Medicine Main Business Overview
11.8.5 Insilico Medicine Latest Developments
11.9 NVIDIA
11.9.1 NVIDIA Company Information
11.9.2 NVIDIA Artificial Intelligence-driven Drug Development Product Offered
11.9.3 NVIDIA Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 NVIDIA Main Business Overview
11.9.5 NVIDIA Latest Developments
11.10 XtalPi
11.10.1 XtalPi Company Information
11.10.2 XtalPi Artificial Intelligence-driven Drug Development Product Offered
11.10.3 XtalPi Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 XtalPi Main Business Overview
11.10.5 XtalPi Latest Developments
11.11 BPGbio
11.11.1 BPGbio Company Information
11.11.2 BPGbio Artificial Intelligence-driven Drug Development Product Offered
11.11.3 BPGbio Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BPGbio Main Business Overview
11.11.5 BPGbio Latest Developments
11.12 Owkin
11.12.1 Owkin Company Information
11.12.2 Owkin Artificial Intelligence-driven Drug Development Product Offered
11.12.3 Owkin Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Owkin Main Business Overview
11.12.5 Owkin Latest Developments
11.13 CytoReason
11.13.1 CytoReason Company Information
11.13.2 CytoReason Artificial Intelligence-driven Drug Development Product Offered
11.13.3 CytoReason Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 CytoReason Main Business Overview
11.13.5 CytoReason Latest Developments
11.14 Deep Genomics
11.14.1 Deep Genomics Company Information
11.14.2 Deep Genomics Artificial Intelligence-driven Drug Development Product Offered
11.14.3 Deep Genomics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Deep Genomics Main Business Overview
11.14.5 Deep Genomics Latest Developments
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Information
11.15.2 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered
11.15.3 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Cloud Pharmaceuticals Main Business Overview
11.15.5 Cloud Pharmaceuticals Latest Developments
11.16 BenevolentAI
11.16.1 BenevolentAI Company Information
11.16.2 BenevolentAI Artificial Intelligence-driven Drug Development Product Offered
11.16.3 BenevolentAI Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BenevolentAI Main Business Overview
11.16.5 BenevolentAI Latest Developments
11.17 Cyclica
11.17.1 Cyclica Company Information
11.17.2 Cyclica Artificial Intelligence-driven Drug Development Product Offered
11.17.3 Cyclica Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Cyclica Main Business Overview
11.17.5 Cyclica Latest Developments
11.18 Verge Genomics
11.18.1 Verge Genomics Company Information
11.18.2 Verge Genomics Artificial Intelligence-driven Drug Development Product Offered
11.18.3 Verge Genomics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Verge Genomics Main Business Overview
11.18.5 Verge Genomics Latest Developments
11.19 Valo Health
11.19.1 Valo Health Company Information
11.19.2 Valo Health Artificial Intelligence-driven Drug Development Product Offered
11.19.3 Valo Health Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Valo Health Main Business Overview
11.19.5 Valo Health Latest Developments
11.20 Envisagenics
11.20.1 Envisagenics Company Information
11.20.2 Envisagenics Artificial Intelligence-driven Drug Development Product Offered
11.20.3 Envisagenics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Envisagenics Main Business Overview
11.20.5 Envisagenics Latest Developments
11.21 Euretos
11.21.1 Euretos Company Information
11.21.2 Euretos Artificial Intelligence-driven Drug Development Product Offered
11.21.3 Euretos Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Euretos Main Business Overview
11.21.5 Euretos Latest Developments
11.22 BioAge Labs
11.22.1 BioAge Labs Company Information
11.22.2 BioAge Labs Artificial Intelligence-driven Drug Development Product Offered
11.22.3 BioAge Labs Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 BioAge Labs Main Business Overview
11.22.5 BioAge Labs Latest Developments
11.23 Iktos
11.23.1 Iktos Company Information
11.23.2 Iktos Artificial Intelligence-driven Drug Development Product Offered
11.23.3 Iktos Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Iktos Main Business Overview
11.23.5 Iktos Latest Developments
11.24 BioSymetrics
11.24.1 BioSymetrics Company Information
11.24.2 BioSymetrics Artificial Intelligence-driven Drug Development Product Offered
11.24.3 BioSymetrics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 BioSymetrics Main Business Overview
11.24.5 BioSymetrics Latest Developments
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Information
11.25.2 Evaxion Biotech Artificial Intelligence-driven Drug Development Product Offered
11.25.3 Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Evaxion Biotech Main Business Overview
11.25.5 Evaxion Biotech Latest Developments
11.26 Aria Pharmaceuticals
11.26.1 Aria Pharmaceuticals Company Information
11.26.2 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered
11.26.3 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Aria Pharmaceuticals Main Business Overview
11.26.5 Aria Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence-driven Drug Development Market Size 2018-2029
2.1.2 Artificial Intelligence-driven Drug Development Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Artificial Intelligence-driven Drug Development Segment by Type
2.2.1 Hardware
2.2.2 Software
2.2.3 Service
2.3 Artificial Intelligence-driven Drug Development Market Size by Type
2.3.1 Artificial Intelligence-driven Drug Development Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
2.4 Artificial Intelligence-driven Drug Development Segment by Application
2.4.1 Early Drug Discovery
2.4.2 Preclinical Phase
2.4.3 Clinical Phase
2.4.4 Regulatory Approval
2.5 Artificial Intelligence-driven Drug Development Market Size by Application
2.5.1 Artificial Intelligence-driven Drug Development Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
3 ARTIFICIAL INTELLIGENCE-DRIVEN DRUG DEVELOPMENT MARKET SIZE BY PLAYER
3.1 Artificial Intelligence-driven Drug Development Market Size Market Share by Players
3.1.1 Global Artificial Intelligence-driven Drug Development Revenue by Players (2018-2023)
3.1.2 Global Artificial Intelligence-driven Drug Development Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence-driven Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE-DRIVEN DRUG DEVELOPMENT BY REGIONS
4.1 Artificial Intelligence-driven Drug Development Market Size by Regions (2018-2023)
4.2 Americas Artificial Intelligence-driven Drug Development Market Size Growth (2018-2023)
4.3 APAC Artificial Intelligence-driven Drug Development Market Size Growth (2018-2023)
4.4 Europe Artificial Intelligence-driven Drug Development Market Size Growth (2018-2023)
4.5 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Artificial Intelligence-driven Drug Development Market Size by Country (2018-2023)
5.2 Americas Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023)
5.3 Americas Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence-driven Drug Development Market Size by Region (2018-2023)
6.2 APAC Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023)
6.3 APAC Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence-driven Drug Development by Country (2018-2023)
7.2 Europe Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023)
7.3 Europe Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence-driven Drug Development by Region (2018-2023)
8.2 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023)
8.3 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE-DRIVEN DRUG DEVELOPMENT MARKET FORECAST
10.1 Global Artificial Intelligence-driven Drug Development Forecast by Regions (2024-2029)
10.1.1 Global Artificial Intelligence-driven Drug Development Forecast by Regions (2024-2029)
10.1.2 Americas Artificial Intelligence-driven Drug Development Forecast
10.1.3 APAC Artificial Intelligence-driven Drug Development Forecast
10.1.4 Europe Artificial Intelligence-driven Drug Development Forecast
10.1.5 Middle East & Africa Artificial Intelligence-driven Drug Development Forecast
10.2 Americas Artificial Intelligence-driven Drug Development Forecast by Country (2024-2029)
10.2.1 United States Artificial Intelligence-driven Drug Development Market Forecast
10.2.2 Canada Artificial Intelligence-driven Drug Development Market Forecast
10.2.3 Mexico Artificial Intelligence-driven Drug Development Market Forecast
10.2.4 Brazil Artificial Intelligence-driven Drug Development Market Forecast
10.3 APAC Artificial Intelligence-driven Drug Development Forecast by Region (2024-2029)
10.3.1 China Artificial Intelligence-driven Drug Development Market Forecast
10.3.2 Japan Artificial Intelligence-driven Drug Development Market Forecast
10.3.3 Korea Artificial Intelligence-driven Drug Development Market Forecast
10.3.4 Southeast Asia Artificial Intelligence-driven Drug Development Market Forecast
10.3.5 India Artificial Intelligence-driven Drug Development Market Forecast
10.3.6 Australia Artificial Intelligence-driven Drug Development Market Forecast
10.4 Europe Artificial Intelligence-driven Drug Development Forecast by Country (2024-2029)
10.4.1 Germany Artificial Intelligence-driven Drug Development Market Forecast
10.4.2 France Artificial Intelligence-driven Drug Development Market Forecast
10.4.3 UK Artificial Intelligence-driven Drug Development Market Forecast
10.4.4 Italy Artificial Intelligence-driven Drug Development Market Forecast
10.4.5 Russia Artificial Intelligence-driven Drug Development Market Forecast
10.5 Middle East & Africa Artificial Intelligence-driven Drug Development Forecast by Region (2024-2029)
10.5.1 Egypt Artificial Intelligence-driven Drug Development Market Forecast
10.5.2 South Africa Artificial Intelligence-driven Drug Development Market Forecast
10.5.3 Israel Artificial Intelligence-driven Drug Development Market Forecast
10.5.4 Turkey Artificial Intelligence-driven Drug Development Market Forecast
10.5.5 GCC Countries Artificial Intelligence-driven Drug Development Market Forecast
10.6 Global Artificial Intelligence-driven Drug Development Forecast by Type (2024-2029)
10.7 Global Artificial Intelligence-driven Drug Development Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 IBM
11.1.1 IBM Company Information
11.1.2 IBM Artificial Intelligence-driven Drug Development Product Offered
11.1.3 IBM Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 IBM Main Business Overview
11.1.5 IBM Latest Developments
11.2 Exscientia
11.2.1 Exscientia Company Information
11.2.2 Exscientia Artificial Intelligence-driven Drug Development Product Offered
11.2.3 Exscientia Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Exscientia Main Business Overview
11.2.5 Exscientia Latest Developments
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Information
11.3.2 Google(Alphabet) Artificial Intelligence-driven Drug Development Product Offered
11.3.3 Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Google(Alphabet) Main Business Overview
11.3.5 Google(Alphabet) Latest Developments
11.4 Microsoft
11.4.1 Microsoft Company Information
11.4.2 Microsoft Artificial Intelligence-driven Drug Development Product Offered
11.4.3 Microsoft Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Microsoft Main Business Overview
11.4.5 Microsoft Latest Developments
11.5 Atomwise
11.5.1 Atomwise Company Information
11.5.2 Atomwise Artificial Intelligence-driven Drug Development Product Offered
11.5.3 Atomwise Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Atomwise Main Business Overview
11.5.5 Atomwise Latest Developments
11.6 Schrodinger
11.6.1 Schrodinger Company Information
11.6.2 Schrodinger Artificial Intelligence-driven Drug Development Product Offered
11.6.3 Schrodinger Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Schrodinger Main Business Overview
11.6.5 Schrodinger Latest Developments
11.7 Aitia
11.7.1 Aitia Company Information
11.7.2 Aitia Artificial Intelligence-driven Drug Development Product Offered
11.7.3 Aitia Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aitia Main Business Overview
11.7.5 Aitia Latest Developments
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Information
11.8.2 Insilico Medicine Artificial Intelligence-driven Drug Development Product Offered
11.8.3 Insilico Medicine Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Insilico Medicine Main Business Overview
11.8.5 Insilico Medicine Latest Developments
11.9 NVIDIA
11.9.1 NVIDIA Company Information
11.9.2 NVIDIA Artificial Intelligence-driven Drug Development Product Offered
11.9.3 NVIDIA Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 NVIDIA Main Business Overview
11.9.5 NVIDIA Latest Developments
11.10 XtalPi
11.10.1 XtalPi Company Information
11.10.2 XtalPi Artificial Intelligence-driven Drug Development Product Offered
11.10.3 XtalPi Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 XtalPi Main Business Overview
11.10.5 XtalPi Latest Developments
11.11 BPGbio
11.11.1 BPGbio Company Information
11.11.2 BPGbio Artificial Intelligence-driven Drug Development Product Offered
11.11.3 BPGbio Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BPGbio Main Business Overview
11.11.5 BPGbio Latest Developments
11.12 Owkin
11.12.1 Owkin Company Information
11.12.2 Owkin Artificial Intelligence-driven Drug Development Product Offered
11.12.3 Owkin Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Owkin Main Business Overview
11.12.5 Owkin Latest Developments
11.13 CytoReason
11.13.1 CytoReason Company Information
11.13.2 CytoReason Artificial Intelligence-driven Drug Development Product Offered
11.13.3 CytoReason Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 CytoReason Main Business Overview
11.13.5 CytoReason Latest Developments
11.14 Deep Genomics
11.14.1 Deep Genomics Company Information
11.14.2 Deep Genomics Artificial Intelligence-driven Drug Development Product Offered
11.14.3 Deep Genomics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Deep Genomics Main Business Overview
11.14.5 Deep Genomics Latest Developments
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Information
11.15.2 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered
11.15.3 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Cloud Pharmaceuticals Main Business Overview
11.15.5 Cloud Pharmaceuticals Latest Developments
11.16 BenevolentAI
11.16.1 BenevolentAI Company Information
11.16.2 BenevolentAI Artificial Intelligence-driven Drug Development Product Offered
11.16.3 BenevolentAI Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BenevolentAI Main Business Overview
11.16.5 BenevolentAI Latest Developments
11.17 Cyclica
11.17.1 Cyclica Company Information
11.17.2 Cyclica Artificial Intelligence-driven Drug Development Product Offered
11.17.3 Cyclica Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Cyclica Main Business Overview
11.17.5 Cyclica Latest Developments
11.18 Verge Genomics
11.18.1 Verge Genomics Company Information
11.18.2 Verge Genomics Artificial Intelligence-driven Drug Development Product Offered
11.18.3 Verge Genomics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Verge Genomics Main Business Overview
11.18.5 Verge Genomics Latest Developments
11.19 Valo Health
11.19.1 Valo Health Company Information
11.19.2 Valo Health Artificial Intelligence-driven Drug Development Product Offered
11.19.3 Valo Health Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Valo Health Main Business Overview
11.19.5 Valo Health Latest Developments
11.20 Envisagenics
11.20.1 Envisagenics Company Information
11.20.2 Envisagenics Artificial Intelligence-driven Drug Development Product Offered
11.20.3 Envisagenics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Envisagenics Main Business Overview
11.20.5 Envisagenics Latest Developments
11.21 Euretos
11.21.1 Euretos Company Information
11.21.2 Euretos Artificial Intelligence-driven Drug Development Product Offered
11.21.3 Euretos Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Euretos Main Business Overview
11.21.5 Euretos Latest Developments
11.22 BioAge Labs
11.22.1 BioAge Labs Company Information
11.22.2 BioAge Labs Artificial Intelligence-driven Drug Development Product Offered
11.22.3 BioAge Labs Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 BioAge Labs Main Business Overview
11.22.5 BioAge Labs Latest Developments
11.23 Iktos
11.23.1 Iktos Company Information
11.23.2 Iktos Artificial Intelligence-driven Drug Development Product Offered
11.23.3 Iktos Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Iktos Main Business Overview
11.23.5 Iktos Latest Developments
11.24 BioSymetrics
11.24.1 BioSymetrics Company Information
11.24.2 BioSymetrics Artificial Intelligence-driven Drug Development Product Offered
11.24.3 BioSymetrics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 BioSymetrics Main Business Overview
11.24.5 BioSymetrics Latest Developments
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Information
11.25.2 Evaxion Biotech Artificial Intelligence-driven Drug Development Product Offered
11.25.3 Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Evaxion Biotech Main Business Overview
11.25.5 Evaxion Biotech Latest Developments
11.26 Aria Pharmaceuticals
11.26.1 Aria Pharmaceuticals Company Information
11.26.2 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered
11.26.3 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Aria Pharmaceuticals Main Business Overview
11.26.5 Aria Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Intelligence-driven Drug Development Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hardware
Table 3. Major Players of Software
Table 4. Major Players of Service
Table 5. Artificial Intelligence-driven Drug Development Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 8. Artificial Intelligence-driven Drug Development Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 11. Global Artificial Intelligence-driven Drug Development Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Player (2018-2023)
Table 13. Artificial Intelligence-driven Drug Development Key Players Head office and Products Offered
Table 14. Artificial Intelligence-driven Drug Development Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Artificial Intelligence-driven Drug Development Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Regions (2018-2023)
Table 19. Global Artificial Intelligence-driven Drug Development Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Artificial Intelligence-driven Drug Development Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Country (2018-2023)
Table 23. Americas Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 25. Americas Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 27. APAC Artificial Intelligence-driven Drug Development Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2018-2023)
Table 29. APAC Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 31. APAC Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 33. Europe Artificial Intelligence-driven Drug Development Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Country (2018-2023)
Table 35. Europe Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 37. Europe Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Artificial Intelligence-driven Drug Development
Table 46. Key Market Challenges & Risks of Artificial Intelligence-driven Drug Development
Table 47. Key Industry Trends of Artificial Intelligence-driven Drug Development
Table 48. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. IBM Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 53. IBM Artificial Intelligence-driven Drug Development Product Offered
Table 54. IBM Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. IBM Main Business
Table 56. IBM Latest Developments
Table 57. Exscientia Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 58. Exscientia Artificial Intelligence-driven Drug Development Product Offered
Table 59. Exscientia Main Business
Table 60. Exscientia Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Exscientia Latest Developments
Table 62. Google(Alphabet) Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 63. Google(Alphabet) Artificial Intelligence-driven Drug Development Product Offered
Table 64. Google(Alphabet) Main Business
Table 65. Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Google(Alphabet) Latest Developments
Table 67. Microsoft Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 68. Microsoft Artificial Intelligence-driven Drug Development Product Offered
Table 69. Microsoft Main Business
Table 70. Microsoft Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Microsoft Latest Developments
Table 72. Atomwise Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 73. Atomwise Artificial Intelligence-driven Drug Development Product Offered
Table 74. Atomwise Main Business
Table 75. Atomwise Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Atomwise Latest Developments
Table 77. Schrodinger Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 78. Schrodinger Artificial Intelligence-driven Drug Development Product Offered
Table 79. Schrodinger Main Business
Table 80. Schrodinger Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Schrodinger Latest Developments
Table 82. Aitia Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 83. Aitia Artificial Intelligence-driven Drug Development Product Offered
Table 84. Aitia Main Business
Table 85. Aitia Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Aitia Latest Developments
Table 87. Insilico Medicine Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 88. Insilico Medicine Artificial Intelligence-driven Drug Development Product Offered
Table 89. Insilico Medicine Main Business
Table 90. Insilico Medicine Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Insilico Medicine Latest Developments
Table 92. NVIDIA Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 93. NVIDIA Artificial Intelligence-driven Drug Development Product Offered
Table 94. NVIDIA Main Business
Table 95. NVIDIA Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. NVIDIA Latest Developments
Table 97. XtalPi Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 98. XtalPi Artificial Intelligence-driven Drug Development Product Offered
Table 99. XtalPi Main Business
Table 100. XtalPi Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. XtalPi Latest Developments
Table 102. BPGbio Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 103. BPGbio Artificial Intelligence-driven Drug Development Product Offered
Table 104. BPGbio Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. BPGbio Main Business
Table 106. BPGbio Latest Developments
Table 107. Owkin Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 108. Owkin Artificial Intelligence-driven Drug Development Product Offered
Table 109. Owkin Main Business
Table 110. Owkin Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Owkin Latest Developments
Table 112. CytoReason Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 113. CytoReason Artificial Intelligence-driven Drug Development Product Offered
Table 114. CytoReason Main Business
Table 115. CytoReason Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. CytoReason Latest Developments
Table 117. Deep Genomics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 118. Deep Genomics Artificial Intelligence-driven Drug Development Product Offered
Table 119. Deep Genomics Main Business
Table 120. Deep Genomics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Deep Genomics Latest Developments
Table 122. Cloud Pharmaceuticals Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 123. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered
Table 124. Cloud Pharmaceuticals Main Business
Table 125. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Cloud Pharmaceuticals Latest Developments
Table 127. BenevolentAI Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 128. BenevolentAI Artificial Intelligence-driven Drug Development Product Offered
Table 129. BenevolentAI Main Business
Table 130. BenevolentAI Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. BenevolentAI Latest Developments
Table 132. Cyclica Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 133. Cyclica Artificial Intelligence-driven Drug Development Product Offered
Table 134. Cyclica Main Business
Table 135. Cyclica Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Cyclica Latest Developments
Table 137. Verge Genomics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 138. Verge Genomics Artificial Intelligence-driven Drug Development Product Offered
Table 139. Verge Genomics Main Business
Table 140. Verge Genomics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Verge Genomics Latest Developments
Table 142. Valo Health Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 143. Valo Health Artificial Intelligence-driven Drug Development Product Offered
Table 144. Valo Health Main Business
Table 145. Valo Health Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Valo Health Latest Developments
Table 147. Envisagenics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 148. Envisagenics Artificial Intelligence-driven Drug Development Product Offered
Table 149. Envisagenics Main Business
Table 150. Envisagenics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Envisagenics Latest Developments
Table 152. Euretos Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 153. Euretos Artificial Intelligence-driven Drug Development Product Offered
Table 154. Euretos Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Euretos Main Business
Table 156. Euretos Latest Developments
Table 157. BioAge Labs Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 158. BioAge Labs Artificial Intelligence-driven Drug Development Product Offered
Table 159. BioAge Labs Main Business
Table 160. BioAge Labs Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. BioAge Labs Latest Developments
Table 162. Iktos Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 163. Iktos Artificial Intelligence-driven Drug Development Product Offered
Table 164. Iktos Main Business
Table 165. Iktos Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Iktos Latest Developments
Table 167. BioSymetrics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 168. BioSymetrics Artificial Intelligence-driven Drug Development Product Offered
Table 169. BioSymetrics Main Business
Table 170. BioSymetrics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. BioSymetrics Latest Developments
Table 172. Evaxion Biotech Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 173. Evaxion Biotech Artificial Intelligence-driven Drug Development Product Offered
Table 174. Evaxion Biotech Main Business
Table 175. Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Evaxion Biotech Latest Developments
Table 177. Aria Pharmaceuticals Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 178. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered
Table 179. Aria Pharmaceuticals Main Business
Table 180. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Aria Pharmaceuticals Latest Developments
Table 1. Artificial Intelligence-driven Drug Development Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hardware
Table 3. Major Players of Software
Table 4. Major Players of Service
Table 5. Artificial Intelligence-driven Drug Development Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 8. Artificial Intelligence-driven Drug Development Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 11. Global Artificial Intelligence-driven Drug Development Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Player (2018-2023)
Table 13. Artificial Intelligence-driven Drug Development Key Players Head office and Products Offered
Table 14. Artificial Intelligence-driven Drug Development Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Artificial Intelligence-driven Drug Development Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Regions (2018-2023)
Table 19. Global Artificial Intelligence-driven Drug Development Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Artificial Intelligence-driven Drug Development Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Country (2018-2023)
Table 23. Americas Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 25. Americas Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 27. APAC Artificial Intelligence-driven Drug Development Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2018-2023)
Table 29. APAC Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 31. APAC Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 33. Europe Artificial Intelligence-driven Drug Development Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Country (2018-2023)
Table 35. Europe Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 37. Europe Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Artificial Intelligence-driven Drug Development
Table 46. Key Market Challenges & Risks of Artificial Intelligence-driven Drug Development
Table 47. Key Industry Trends of Artificial Intelligence-driven Drug Development
Table 48. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. IBM Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 53. IBM Artificial Intelligence-driven Drug Development Product Offered
Table 54. IBM Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. IBM Main Business
Table 56. IBM Latest Developments
Table 57. Exscientia Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 58. Exscientia Artificial Intelligence-driven Drug Development Product Offered
Table 59. Exscientia Main Business
Table 60. Exscientia Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Exscientia Latest Developments
Table 62. Google(Alphabet) Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 63. Google(Alphabet) Artificial Intelligence-driven Drug Development Product Offered
Table 64. Google(Alphabet) Main Business
Table 65. Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Google(Alphabet) Latest Developments
Table 67. Microsoft Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 68. Microsoft Artificial Intelligence-driven Drug Development Product Offered
Table 69. Microsoft Main Business
Table 70. Microsoft Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Microsoft Latest Developments
Table 72. Atomwise Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 73. Atomwise Artificial Intelligence-driven Drug Development Product Offered
Table 74. Atomwise Main Business
Table 75. Atomwise Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Atomwise Latest Developments
Table 77. Schrodinger Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 78. Schrodinger Artificial Intelligence-driven Drug Development Product Offered
Table 79. Schrodinger Main Business
Table 80. Schrodinger Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Schrodinger Latest Developments
Table 82. Aitia Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 83. Aitia Artificial Intelligence-driven Drug Development Product Offered
Table 84. Aitia Main Business
Table 85. Aitia Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Aitia Latest Developments
Table 87. Insilico Medicine Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 88. Insilico Medicine Artificial Intelligence-driven Drug Development Product Offered
Table 89. Insilico Medicine Main Business
Table 90. Insilico Medicine Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Insilico Medicine Latest Developments
Table 92. NVIDIA Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 93. NVIDIA Artificial Intelligence-driven Drug Development Product Offered
Table 94. NVIDIA Main Business
Table 95. NVIDIA Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. NVIDIA Latest Developments
Table 97. XtalPi Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 98. XtalPi Artificial Intelligence-driven Drug Development Product Offered
Table 99. XtalPi Main Business
Table 100. XtalPi Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. XtalPi Latest Developments
Table 102. BPGbio Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 103. BPGbio Artificial Intelligence-driven Drug Development Product Offered
Table 104. BPGbio Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. BPGbio Main Business
Table 106. BPGbio Latest Developments
Table 107. Owkin Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 108. Owkin Artificial Intelligence-driven Drug Development Product Offered
Table 109. Owkin Main Business
Table 110. Owkin Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Owkin Latest Developments
Table 112. CytoReason Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 113. CytoReason Artificial Intelligence-driven Drug Development Product Offered
Table 114. CytoReason Main Business
Table 115. CytoReason Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. CytoReason Latest Developments
Table 117. Deep Genomics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 118. Deep Genomics Artificial Intelligence-driven Drug Development Product Offered
Table 119. Deep Genomics Main Business
Table 120. Deep Genomics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Deep Genomics Latest Developments
Table 122. Cloud Pharmaceuticals Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 123. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered
Table 124. Cloud Pharmaceuticals Main Business
Table 125. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Cloud Pharmaceuticals Latest Developments
Table 127. BenevolentAI Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 128. BenevolentAI Artificial Intelligence-driven Drug Development Product Offered
Table 129. BenevolentAI Main Business
Table 130. BenevolentAI Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. BenevolentAI Latest Developments
Table 132. Cyclica Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 133. Cyclica Artificial Intelligence-driven Drug Development Product Offered
Table 134. Cyclica Main Business
Table 135. Cyclica Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Cyclica Latest Developments
Table 137. Verge Genomics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 138. Verge Genomics Artificial Intelligence-driven Drug Development Product Offered
Table 139. Verge Genomics Main Business
Table 140. Verge Genomics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Verge Genomics Latest Developments
Table 142. Valo Health Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 143. Valo Health Artificial Intelligence-driven Drug Development Product Offered
Table 144. Valo Health Main Business
Table 145. Valo Health Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Valo Health Latest Developments
Table 147. Envisagenics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 148. Envisagenics Artificial Intelligence-driven Drug Development Product Offered
Table 149. Envisagenics Main Business
Table 150. Envisagenics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Envisagenics Latest Developments
Table 152. Euretos Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 153. Euretos Artificial Intelligence-driven Drug Development Product Offered
Table 154. Euretos Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Euretos Main Business
Table 156. Euretos Latest Developments
Table 157. BioAge Labs Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 158. BioAge Labs Artificial Intelligence-driven Drug Development Product Offered
Table 159. BioAge Labs Main Business
Table 160. BioAge Labs Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. BioAge Labs Latest Developments
Table 162. Iktos Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 163. Iktos Artificial Intelligence-driven Drug Development Product Offered
Table 164. Iktos Main Business
Table 165. Iktos Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Iktos Latest Developments
Table 167. BioSymetrics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 168. BioSymetrics Artificial Intelligence-driven Drug Development Product Offered
Table 169. BioSymetrics Main Business
Table 170. BioSymetrics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. BioSymetrics Latest Developments
Table 172. Evaxion Biotech Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 173. Evaxion Biotech Artificial Intelligence-driven Drug Development Product Offered
Table 174. Evaxion Biotech Main Business
Table 175. Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Evaxion Biotech Latest Developments
Table 177. Aria Pharmaceuticals Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors
Table 178. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered
Table 179. Aria Pharmaceuticals Main Business
Table 180. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Aria Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Artificial Intelligence-driven Drug Development Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence-driven Drug Development Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Artificial Intelligence-driven Drug Development Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Artificial Intelligence-driven Drug Development Sales Market Share by Country/Region (2022)
Figure 8. Artificial Intelligence-driven Drug Development Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type in 2022
Figure 10. Artificial Intelligence-driven Drug Development in Early Drug Discovery
Figure 11. Global Artificial Intelligence-driven Drug Development Market: Early Drug Discovery (2018-2023) & ($ Millions)
Figure 12. Artificial Intelligence-driven Drug Development in Preclinical Phase
Figure 13. Global Artificial Intelligence-driven Drug Development Market: Preclinical Phase (2018-2023) & ($ Millions)
Figure 14. Artificial Intelligence-driven Drug Development in Clinical Phase
Figure 15. Global Artificial Intelligence-driven Drug Development Market: Clinical Phase (2018-2023) & ($ Millions)
Figure 16. Artificial Intelligence-driven Drug Development in Regulatory Approval
Figure 17. Global Artificial Intelligence-driven Drug Development Market: Regulatory Approval (2018-2023) & ($ Millions)
Figure 18. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application in 2022
Figure 19. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Player in 2022
Figure 20. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Artificial Intelligence-driven Drug Development Market Size 2018-2023 ($ Millions)
Figure 22. APAC Artificial Intelligence-driven Drug Development Market Size 2018-2023 ($ Millions)
Figure 23. Europe Artificial Intelligence-driven Drug Development Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size 2018-2023 ($ Millions)
Figure 25. Americas Artificial Intelligence-driven Drug Development Value Market Share by Country in 2022
Figure 26. United States Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Region in 2022
Figure 31. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Type in 2022
Figure 32. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Application in 2022
Figure 33. China Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Country in 2022
Figure 40. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Figure 41. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Figure 42. Germany Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 56. APAC Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 57. Europe Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 59. United States Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 60. Canada Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 63. China Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 64. Japan Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 65. Korea Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 67. India Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 68. Australia Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 69. Germany Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 70. France Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 71. UK Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 72. Italy Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 73. Russia Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 74. Spain Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 77. Israel Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 80. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Artificial Intelligence-driven Drug Development Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence-driven Drug Development Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Artificial Intelligence-driven Drug Development Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Artificial Intelligence-driven Drug Development Sales Market Share by Country/Region (2022)
Figure 8. Artificial Intelligence-driven Drug Development Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type in 2022
Figure 10. Artificial Intelligence-driven Drug Development in Early Drug Discovery
Figure 11. Global Artificial Intelligence-driven Drug Development Market: Early Drug Discovery (2018-2023) & ($ Millions)
Figure 12. Artificial Intelligence-driven Drug Development in Preclinical Phase
Figure 13. Global Artificial Intelligence-driven Drug Development Market: Preclinical Phase (2018-2023) & ($ Millions)
Figure 14. Artificial Intelligence-driven Drug Development in Clinical Phase
Figure 15. Global Artificial Intelligence-driven Drug Development Market: Clinical Phase (2018-2023) & ($ Millions)
Figure 16. Artificial Intelligence-driven Drug Development in Regulatory Approval
Figure 17. Global Artificial Intelligence-driven Drug Development Market: Regulatory Approval (2018-2023) & ($ Millions)
Figure 18. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application in 2022
Figure 19. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Player in 2022
Figure 20. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Artificial Intelligence-driven Drug Development Market Size 2018-2023 ($ Millions)
Figure 22. APAC Artificial Intelligence-driven Drug Development Market Size 2018-2023 ($ Millions)
Figure 23. Europe Artificial Intelligence-driven Drug Development Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size 2018-2023 ($ Millions)
Figure 25. Americas Artificial Intelligence-driven Drug Development Value Market Share by Country in 2022
Figure 26. United States Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Region in 2022
Figure 31. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Type in 2022
Figure 32. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Application in 2022
Figure 33. China Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Country in 2022
Figure 40. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Figure 41. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Figure 42. Germany Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Artificial Intelligence-driven Drug Development Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 56. APAC Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 57. Europe Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 59. United States Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 60. Canada Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 63. China Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 64. Japan Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 65. Korea Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 67. India Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 68. Australia Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 69. Germany Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 70. France Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 71. UK Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 72. Italy Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 73. Russia Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 74. Spain Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 77. Israel Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Artificial Intelligence-driven Drug Development Market Size 2024-2029 ($ Millions)
Figure 80. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Application (2024-2029)
